期刊文献+

肺癌患者外周血单个核细胞分泌IL-1、IL-4、IL-6水平的研究 被引量:3

The Levels of Interleukin-1,Interleukin-4, and Interleukin-6 Production in Patients with Lung Cancer
下载PDF
导出
摘要 目的 :研究肺癌患者外周血单个核细胞 (PBMCs)分泌 IL- 1、IL- 4、IL- 6的水平 ,及根治手术对其影响。方法 :分别采用生物学方法及酶联免疫方法测定 40例肺癌手术前、14例肺癌根治手术前后、30例正常对照者及 2 2例肺部良性疾病者细胞因子的水平。结果 :肺癌组分泌 IL- 1、IL- 4、IL- 6 (分别为 0 .5 6 6± 0 .10 2 ,7.918± 5 .0 71pg/ ml,3.499± 2 .0 88)均低于正常对照组 (分别为 0 .6 40± 0 .12 3,19.2 97± 10 .6 85 pg/ ml,5 .372± 0 .113,均 P <0 .0 1) ,且相互间无相关性。根治手术后产生 IL- 1、IL- 4水平明显提高 (分别为 t=5 .0 6 7,P <0 .0 1;t=2 .2 44 ,P <0 .0 5 )。结论 :检测 PBMCs分泌 IL- 1、IL- 4水平对肺癌的诊断有较好的敏感性和特异性 ,联合检测意义更大 ,且对监测疗效 ,提示预后也有重要的临床意义。 Objective:Our purpose was to study the levels of interleukin-1(IL-1), interleukin-4(IL-4), and interleukin-6(IL-6) in patients with lung cancer before and after radical therapy. Methods:We investigated fourty patients with lung cancer. Fourteen of them underwent radical operation. Thirty healthy controls and 22 pulmonary benign disorder controls were enrolled for possible confounded factors. Levels of IL-1 was detected by biological assay, IL-4 and IL-6 were detected by ELISA.Results:The levels of IL-1,IL-4, and IL-6 were significantly lower in lung cancer groups(0.566±0.102,7.918±5.071 pg/ml, 3.499±2.088, respectively)thanthoseinhealthy controls(0.640±0.123,19.297±10.685 pg/ml, 5.372±0.113, respectively, P< 0.01 ). Therewerenocorrelationamongthese cytokines.Furthermore, the activitiesofIL-1and IL-4 inpostoperativegroupswereobviouslyincreasedthanthoseinpreoperativeones(t=5.067,P<0.01, t=2.244, P<0.05, respectively) Conclusion:The levels of IL-1, IL-4 were relatively sensitive and specific for diagnosis of lung cancer, and they were also helpful in evaluating the therapeutic effect and prognosis.
出处 《中国医科大学学报》 CSCD 北大核心 2000年第4期272-273,275,共3页 Journal of China Medical University
关键词 肺癌 外周血单个核细胞 IL-1 IL-4 IL-6 lung cancer peripheral blood mononuclear cells cytokines
  • 相关文献

参考文献1

  • 1焦光宇,中华结核和呼吸杂志,1996年,19卷,5期,289页

同被引文献13

  • 1吴家明.肺癌患者血清IL-6,IL-8和TNF活性测定的临床意义[J].放射免疫学杂志,2004,17(5):354-355. 被引量:14
  • 2李光宇.肿瘤坏死因子与肿瘤的研究进展[J].中国肿瘤临床,1995,22(11):814-818. 被引量:6
  • 3吕志敢,郭政.肿瘤坏死因子的研究进展[J].山西医科大学学报,2006,37(3):311-314. 被引量:79
  • 4何伟珍,古洁若.白介素-8受体α和β的研究进展[J].新医学,2006,37(11):766-768. 被引量:10
  • 5Kishimoto T. The Biology of Interleukin-6. Blood,1989,74:1.
  • 6Williams N. Tumor cells fight back to beat immune system ( news;commet). Science, 1996,274(5291 ) :1302 -1305.
  • 7Saito K, Ishikura H, Kishimoto T, et al. Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells. Int J Cancer, 1998,75 (2) :284 - 289.
  • 8Simith DR, Plovenni PG, Kunkel SL,et al. Inhibition of interleukin-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Mxp Med,1994,179(5) :1499 ~ 1501.
  • 9Luca M, Huang S, Gershenwald JE,et al. Expression of interleukin-8by human melanoma cell up -regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol,1997,151 (4) :1105-1113.
  • 10Wu S,Boyer CM,Whitaker RS,et al. Tumor necrosis factor-α as an autocrine and paracrine growth factor for ovarian cancer. Monokine induction of tumor cell proliferation and tumor necrosis factor-α expression. Cancer Res, 1993,53 : 1939 - 1941.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部